🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

444 results for “Ology” Clear

  1. Pegasys 180 micrograms solution for injection in pre-filled syringe, VIR-3434, Viread 245 mg film-coated tablets, VIR-2218

    Vir Biotechnology

    Chronic Hepatitis B Virus (HBV) Infection

    phase 2 small molecule active

    1 trial

  2. Pembrolizumab

    ALX ONCOLOGY HOLDINGS INC

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  3. Pembrolizumab (KEYTRUDA®) and PDS0101

    PDS Biotechnology Corp

    Metastatic Head and Neck Cancer

    phase 2 other completed

    1 trial

  4. Phase 1/2 Study of PYX-201 in Combination with Pembrolizumab in Advanced Solid Tumors

    Pyxis Oncology

    Advanced Solid Tumors

    phase 2 other active

    1 trial

  5. Piqray 50 mg and 200 mg film-coated tablets

    Ology Bioservices Ireland LTD

    metasatic breast cancer, hormon positive, her 2 negative

    phase 2 small molecule active

    1 trial

  6. Placebo

    Cardiff Oncology

    Tuberous Sclerosis

    phase 2 small molecule active

    1 trial

  7. Placebo

    Cardiff Oncology

    Metastatic Breast Cancer

    phase 2 small molecule terminated

    1 trial

  8. Placebo de macitentan 10 mg, MACITENTAN

    Pari Pharma GmbH

    Inoperable Chronic thromboembolic pulmonary hyperTension, Pneumology

    phase 2 small molecule active

    1 trial

  9. Placebo for AMG 133, AMG 133

    Amgen Technology (Ireland) UC

    Type 2 Diabetes Mellitus

    phase 2 small molecule active

    1 trial

  10. Placebo for AMG 451, Rocatinlimab

    Amgen Technology (Ireland) UC

    Moderate-to-severe Asthma

    phase 2 small molecule active

    1 trial

  11. Placebo for AMG 732 will consist of site-sourced normal saline in sterile single-use vials or ampoules, AMG 732

    Amgen Technology (Ireland) UC

    Thyroid Eye Disease

    phase 2 small molecule active

    1 trial

  12. Plerixafor

    Cardiff Oncology

    Acute Myeloid Leukaemia

    phase 2 small molecule completed

    1 trial

  13. Ponatinib

    Cardiff Oncology

    Acute Lymphoblastic Leukemia, Adult

    phase 2 small molecule active

    1 trial

  14. Pro insulin peptide

    Cardiff Oncology

    Type 1 Diabetes

    phase 2 small molecule completed

    1 trial

  15. Rydapt 25 mg soft capsules, Dacogen 50 mg powder for concentrate for solution for infusion., Rydapt 25 mg soft capsules

    Ology Bioservices Ireland LTD

    Acute myeloid leukemia, Myelodysplastic syndrome

    phase 2 small molecule active

    1 trial

  16. SALINE, OTHER PLASMA PROTEIN FRACTIONS , Octaplasma 45-70 mg/ml pulver og væske til infusjonsvæske, oppløsning, Saline (NaCl)

    Ology Bioservices Ireland LTD

    Early symptomatic phase Alzheimer's disease

    phase 2 small molecule active

    1 trial

  17. SELPERCATINIB, SELPERCATINIB

    Ology Bioservices Ireland LTD

    Male or female patients age 12 years or older with a locally advanced or metastatic solid tumor with evidence of a RET gene alteration in tumor and/or blood.

    phase 2 small molecule active

    1 trial

  18. SELPERCATINIB, Selpercatinib, Selpercatinib, SELPERCATINIB, Selpercatinib

    Ology Bioservices Ireland LTD

    Pediatric Patients with Advanced RET-Altered Solid or Primary Central Nervous System Tumors

    phase 2 small molecule active

    1 trial

  19. SILTUXIMAB, Tarlatamab, Tarlatamab

    Amgen Technology (Ireland) UC

    Small Cell Lung Cancer (SCLC)

    phase 2 small molecule active

    1 trial

  20. SOTORASIB

    Amgen Technology (Ireland) UC

    KRAS p.G12C Mutant Advanced Solid Tumors

    phase 2 small molecule active

    1 trial

  21. SOTORASIB

    Amgen Technology (Ireland) UC

    Non-small cell lung cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  22. SRF388

    Coherus Oncology

    Hepatocellular Carcinoma

    phase 2 small molecule completed

    1 trial

  23. STC-15 in combination with toripalimab

    Coherus Oncology

    Solid Tumor

    phase 2 other active

    1 trial

  24. SUL-238, Identical to test product except without active substance

    Sana Biotechnology

    Parkinson’s Disease

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources